Know Cancer

or
forgot password

Prospective Study Analyzing Value of Breast Density Change Predicting ENdocrine Therapy Response in Postmenopausal Women Taking Adjuvant ARomatase Inhibitor


N/A
N/A
70 Years
Not Enrolling
Female
Invasive Breast Cancer, Estrogen Receptor Positive

Thank you

Trial Information

Prospective Study Analyzing Value of Breast Density Change Predicting ENdocrine Therapy Response in Postmenopausal Women Taking Adjuvant ARomatase Inhibitor


Inclusion criteria ER positive breast cancer Postmenopause women Older than 60yr S/P
bilateral salphingo-oophorectomy No menstruation history within 1yr and FSH>30mIU/mL
Ipsilateral invasive breast cancer Undergone curative resection No evidence of distant
metastasis Capable of breast MRI


Inclusion Criteria:



- ER positive invasive breast cancer Postmenopause women age 60yrs or older s/p
bilateral salphingo-oophorectomy No history of menstruation and FSH>30mIU Planned for
aromatase inhibitor Unilateral breast cancer Curative resection No evidence of
distant metastasis

Exclusion Criteria:

- Bilateral breast cancer Male breast cancer Acceptable for breast MRI Pregnancy or
lactation

Type of Study:

Observational [Patient Registry]

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

disease free survival

Outcome Description:

recurrence locoregional distant metastasis Confirmed by clinical imaging or pathology

Outcome Time Frame:

5 year

Safety Issue:

No

Principal Investigator

Wonshik Han, MD PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

SNUH

Authority:

Korea: Institutional Review Board

Study ID:

SNUHBCC001

NCT ID:

NCT01765049

Start Date:

January 2013

Completion Date:

December 2018

Related Keywords:

  • Invasive Breast Cancer
  • Estrogen Receptor Positive
  • breast density change
  • endocrine therapy response
  • aromatase inhibitor
  • Breast Neoplasms

Name

Location